*POSTPONED* Real-World Evidence 2020: Rare Diseases and Innovative Therapies

Wednesday 01 April, 2020 - Thursday 02 April, 2020 starting at 08:15 - 17:00

17, One Crosswall, America Square, London EC3N 2LB, UK

Join MAP’s CEO Christian Hill for Real-World Evidence 2020: Rare Diseases and Innovative Therapies

Join the Journal of Comparative Effectiveness Research and The Evidence Base® for Real-World Evidence 2020: Rare Diseases and Innovative Therapies, the industry’s first European RWE event solely focused on rare diseases and innovative therapies.

RWE 2020: Rare Diseases and Innovative Therapies convenes stakeholders across the RWE ecosystem to explore the practical application of RWE to rare diseases and next-generation treatments. On 1–2 April, you will hear from leading national and international, including:

  • Chair: Charles Makin, Global Head Real-World Evidence Strategy, Biogen
  • Christian Hill, CEO, MAP BioPharma
  • Joanne Hackett, CCO, Genomics England
  • Karen Facey, Senior Research Fellow, IMPACT HTA WP10 Appraisal of Orphan Medicinal Products
  • Panos Kefalas, Head of Health Economics and Market Access, Cell and Gene Therapy Catapult
  • Paolo Morgese, EU Director of Market Access and Member Relations, Alliance for Regenerative Medicine

More information | Agenda | Register

Tagged with

The Location

17, One Crosswall, America Square, London EC3N 2LB, UK

Event Location is here:
17, One Crosswall, America Square, London EC3N 2LB, UK

Published on 14. January 2020 in

Back to the Events Page